The objective of this retrospective cohort study is to assess the association between insulin use and glycemic control, as measured by changes in hemoglobin A1c (A1c) levels, among patients with type 2 diabetes mellitus during the COVID-19 pandemic. The gene discussed is INS; the disease is diabetes mellitus.